Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cidara Therapeutics, Inc. | Chief Financial Officer | Common Stock | 336K | $232K | $0.69 | Mar 15, 2024 | Direct |
Cidara Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 218K | Mar 15, 2024 | Direct | ||
Cidara Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 130K | Sep 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CDTX | Cidara Therapeutics, Inc. | Sep 30, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Chief Financial Officer |
CDTX | Cidara Therapeutics, Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 20, 2024 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Mar 11, 2024 | 1 | -$12.7K | 4 | Mar 12, 2024 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Mar 27, 2023 | 2 | $0 | 4 | Mar 29, 2023 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Mar 13, 2023 | 1 | -$10.2K | 4 | Mar 13, 2023 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Sep 15, 2022 | 3 | -$12K | 4 | Sep 19, 2022 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Mar 31, 2022 | 4 | -$20.6K | 4 | Apr 4, 2022 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Nov 12, 2021 | 1 | $30.8K | 4 | Nov 15, 2021 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Sep 1, 2021 | 2 | $0 | 4 | Sep 3, 2021 | CFO & CBO |
CDTX | Cidara Therapeutics, Inc. | Sep 1, 2021 | 0 | $0 | 3 | Sep 3, 2021 | CFO & CBO |